Chang et al. demonstrated that an interaction between the Robo1 receptor on cancer cells and the ligand Slit2, secreted by fibroblasts, blocks β-catenin nuclear translocation and downregulates c-myc and cyclin D1 [74]. The gene discussed is SLIT2; the disease is cancer.